CYTOKINETICS, INCORPORATED
CYTK · NASDAQ
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function.
Market Data
Price
$63.97
+4.39 (+7.37%)
Market Cap$7.34B
P/E Ratio—
EPS$—
52W High$70.98
52W Low$29.31
Beta0.31
Data from Finnhub · Updated Apr 30, 2026